InsidersTradesSigma
Track the 九典制药 share price and the full insider trade history of the company, a listed issuer based in China. Shares trade on the CN market, under the oversight of SSE / SZSE (CSRC). Operating in the Health Care sector, 九典制药 has published 6 public disclosures. Market capitalisation: €5.4bn. The latest transaction was disclosed on 27 June 2025 (Sale). Among the most active insiders: 梁胜华. The full history is openly available.
6
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
€9m
6 ops.
Sell Volume
22Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 3,943 of 29,063 companies
71.0
score / 100
Value63
Quality79
FCF yld-0.1%
Earn yld8.8%
EV/EBITDA8.9x
ROE15%
Gross mgn73%
Net mgn15%
Debt/EBITDA0.8x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 27 June 2025
Declarations6 total
6 of 6 declarations
关于 九典制药
九典制药是一家专注于健康和制药领域的公司，提供一系列药品。该公司在 XSHE 市场上市。